Over 450 Total Lots Up For Auction at Three Locations - CO 05/12, PA 05/15, NY 05/20

Study validates equivalency of pen-and-paper cognitive assessment with digital counterpart to detect early dementias

Press releases may be edited for formatting or style | July 17, 2017 Alzheimers/Neurology


About SAGE Test
The Self-administered Gerocognitive Examination (SAGE) is a brief cognitive assessment for mild cognitive impairment (MCI) and early dementia, created by Dr. Douglas Scharre, Professor of Clinical Neurology and Psychiatry at The Ohio State Wexner Medical Center in Columbus, Ohio. It was validated in the setting of mild cognitive impairment, and has subsequently been adopted in numerous other settings clinically. SAGE has the advantage of self-administration, brevity, and 4 interchangeable forms to avoid retest and practice biases. For more information visit: https://sagetest.osu.edu

stats Advertisement
DOTmed text ad

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

stats
About BrainTest Inc.
BrainTest is a medical software company that provides scientifically validated cognitive screening instruments on a wide range of tablets and mobile devices. The company empowers patients to monitor their cognition and learn objective evidence-based recommendations about their brain health in the comfort and privacy of their own homes. Through its partnership with The Ohio State University, BrainTest holds the exclusive digital rights to the Self-Administered Gerocognitive Examination (SAGE Test). For more information visit https://braintest.com

Back to HCB News

You Must Be Logged In To Post A Comment